批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 1995/06/07 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
STANDARD
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2025/02/03 |
SUPPL-35(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2022/11/01 |
SUPPL-34(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2022/05/19 |
SUPPL-32(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2022/03/01 |
SUPPL-28(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2022/03/01 |
SUPPL-27(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2022/03/01 |
SUPPL-24(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2022/03/01 |
SUPPL-23(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2017/04/27 |
SUPPL-30(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2015/10/26 |
SUPPL-29(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2014/03/11 |
SUPPL-26(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2014/03/11 |
SUPPL-25(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2012/08/16 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2012/08/16 |
SUPPL-19(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2010/01/21 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2006/06/27 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2005/06/21 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2003/06/27 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2002/12/11 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2002/05/24 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2001/09/28 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 2001/08/09 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2001/03/30 |
SUPPL-6(补充) |
Approval |
Efficacy-Labeling Change With Clinical Data |
STANDARD
|
|
|
| 2001/03/14 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 2000/06/16 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC)-Packaging |
STANDARD
|
|
|
| 1998/08/06 |
SUPPL-3(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 1997/12/23 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 1997/07/02 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC)-Packaging |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
>>>活性成分:SEVOFLURANE; 剂型/给药途径:LIQUID;INHALATION; 规格:100%; 治疗等效代码:AN<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 020478 |
001 |
NDA |
ULTANE |
SEVOFLURANE |
LIQUID;INHALATION |
100% |
Prescription |
Yes |
Yes |
AN |
1995/06/07
|
ABBVIE |
| 075895 |
001 |
ANDA |
SEVOFLURANE |
SEVOFLURANE |
LIQUID;INHALATION |
100% |
Prescription |
No |
No |
AN |
2002/07/02
|
BAXTER HLTHCARE |
| 077867 |
001 |
ANDA |
SOJOURN |
SEVOFLURANE |
LIQUID;INHALATION |
100% |
Prescription |
No |
No |
AN |
2007/05/02
|
PIRAMAL CRITICAL |
| 078650 |
001 |
ANDA |
SEVOFLURANE |
SEVOFLURANE |
LIQUID;INHALATION |
100% |
Prescription |
No |
No |
AN |
2007/11/19
|
HALOCARBON PRODS |
| 203793 |
001 |
ANDA |
SEVOFLURANE |
SEVOFLURANE |
LIQUID;INHALATION |
100% |
Prescription |
No |
No |
AN |
2015/11/03
|
SHANGHAI HENGRUI |
| 214382 |
001 |
ANDA |
SEVOFLURANE |
SEVOFLURANE |
LIQUID;INHALATION |
100% |
Prescription |
No |
No |
AN |
2023/08/18
|
SHANDONG |